Current Neuro-Oncology
Volume
25 Number 21
15 November 2023
Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 21, 15 November
He YZ, Zhou Q, Deng WY, Huang LY,
Lu YY, Ruan YY, Du H.
Clinical
characteristics and prognostic factors of surgical treatment in
children with brainstem tumor.
Eur
Rev Med Pharmacol Sci. 2023 Nov;27(22):10926-10934∟.
doi: 10.26355/eurrev_202311_34460∟.
PMID: 38039022∟.
Observational study. ˍ
Szekeres D, Jetty SN, Soni N.
The
Role of Multiparametric MRI in Diagnosing and Grading
Glioma.
Neurol
India. 2023
Nov-Dec;71(6):1274-1275. doi:
10.4103/0028-3886.391347. PMID:
38174478. Letter, Case report. ˍ
Bhati V, Kumar A, Lather V, Sharma
R, Pandita D.
Association
of temozolomide with progressive multifocal leukoencephalopathy: a
disproportionality analysis integrated with network
pharmacology.
Expert
Opin Drug Saf. 2023 Nov 1∟.
doi: 10.1080/14740338.2023.2278682∟.
PMID: 37915230∟.
Observational study˰ ˍ
Blay JY, Cropet C, Mansard S,
Loriot Y, De La Fouchardière C, Haroche J, Topart D,
Tougeron D, You B, Italiano A, Le Brun-Ly V, Ferrero JM, Penel N,
Fabbro M, Troussard X, Malka D, Ray-Coquard I, Leboulleux S,
Fléchon A, Maubec E, Charles J, Dalle S, Taieb S, Garcia
GCTE, Mandache AM, Colignon N, Gavrel M, Nowak F, Hoog Labouret N,
Mahier Aït Oukhatar C, Gomez-Roca C.
Long
term activity of vemurafenib in cancers with BRAF mutations: the
ACSE basket study for advanced cancers other than BRAFV600-mutated
melanoma.
ESMO
Open. 2023 Nov 1;8(6):102038∟.
doi: 10.1016/j.esmoop.2023.102038∟.
PMID: 37922690∟.
Interventional study. ˍ
Khang M, Lee JH, Lee T, Suh HW, Lee
S, Cavaliere A, Rushing A, Geraldo LH, Belitzky E, Rossano S, de
Feyter HM, Shin K, Huttner A, Roussel MF, Thomas JL, Carson RE,
Marquez-Nostra B, Bindra RS, Saltzman WM.
Intrathecal
delivery of nanoparticle PARP inhibitor to the cerebrospinal fluid
for the treatment of metastatic medulloblastoma.
Sci
Transl Med. 2023 Nov 1;15(720):eadi1617∟.
doi: 10.1126/scitranslmed.adi1617∟.
PMID: 37910601∟.
Laboratory investigation˰ ˍ
*
Li X, Gong J.
Survival
nomogram for medulloblastoma and multi-center external validation
cohort.
Front
Pharmacol. 2023 Nov 2;14:1247812∟.
doi: 10.3389/fphar.2023.1247812∟.
PMID: 38026968∟.
Observational study. ˍ
*
Yamada S, Tanikawa M, Matsushita Y,
Fujinami R, Yamada H, Sakomi K, Sakata T, Inagaki H, Yokoo H,
Ichimura K, Mase M.
SEGA-like
circumscribed astrocytoma in a non-NF1 patient, harboring
molecular profile of GBM. A case report.
Neuropathology.
2023 Nov 2∟.
doi: 10.1111/neup.12948∟.
PMID: 37919875∟.
Case report˰ ˍ
Aum DJ, Reynolds RA, McEvoy SD,
Wong M, Roland JL, Smyth MD.
Laser
interstitial thermal therapy compared with open resection for
treating subependymal giant cell astrocytoma.
J
Neurosurg Pediatr. 2023 Nov 3:1-10∟.
doi: 10.3171/2023.8.PEDS23370∟.
PMID: 37922551∟.
Observational study˰ ˍ
*
Das A, Gaikwad U, Krishnan G,
Rajendran A, Patil S, Subramaniam P, Krishna U, Wakde MG,
Chilukuri S, Jalali R.
Successful
Implementation of Image-Guided Pencil-Beam Scanning Proton Therapy
in Medulloblastomas.
Diagnostics
(Basel). 2023 Nov 3;13(21):3378∟.
doi: 10.3390/diagnostics13213378∟.
PMID: 37958274∟.
Observational study. ˍ
Kuo CC, Monteiro A, Lim J, Brown
NJ, Recker MJ, Ghannam MM, Gendreau JL, Li V, Reynolds RM.
An
online calculator using machine learning for predicting survival
in pediatric patients with medulloblastoma.
J
Neurosurg Pediatr. 2023 Nov 3:1-10∟.
doi: 10.3171/2023.8.PEDS2352∟.
PMID: 37922543∟.
Observational study˰ ˍ
*
Lemarié A, Lubrano V, Delmas
C, Lusque A, Cerapio JP, Perrier M, Siegfried A, Arnauduc F,
Nicaise Y, Dahan P, Filleron T, Mounier M, Toulas C,
Cohen-Jonathan Moyal E.
The
STEMRI trial: Magnetic resonance spectroscopy imaging can define
tumor areas enriched in glioblastoma stem-like cells.
Sci
Adv. 2023 Nov 3;9(44):eadi0114∟. doi:
10.1126/sciadv.adi0114∟.
PMID: 37922359∟.
Interventional study. ˍ
Willmann J, Leiser D, Weber
DC.
Oncological
Outcomes, Long-Term Toxicities, Quality of Life and Sexual Health
after Pencil-Beam Scanning Proton Therapy in Patients with
Low-Grade Glioma.
Cancers
(Basel). 2023 Nov 4;15(21):5287∟.
doi: 10.3390/cancers15215287∟.
PMID: 37958460∟.
Observational study. ˍ
Elsayed A, Alardati H, Al-Maghrabi
J, Meliti A.
Extracranial
Medulloblastoma With Myogenic Differentiation: Report of a Rare
Event.
Cureus.
2023 Nov 5;15(11):e48301∟.
doi: 10.7759/cureus.48301∟.
PMID: 38058319∟.
Case report. ˍ
*
Iv M, Naya L, Sanan S, Van Buskirk
SL, Nagpal S, Thomas RP, Recht LD, Patel CB.
Tumor
treating fields increases blood-brain barrier permeability and
relative cerebral blood volume in patients with
glioblastoma.
Neuroradiol
J. 2023 Nov 6:19714009231207083∟.
doi: 10.1177/19714009231207083∟.
PMID: 37931176∟.
Observational study. ˍ
Ling AL, Chiocca EA.
Oncolytic
immunoactivation associates with survival in a glioblastoma
clinical trial.
Neuro
Oncol. 2023 Nov 6:noad216∟.
doi: 10.1093/neuonc/noad216∟.
PMID: 37941468∟.
Editorial˰ ˍ
Rautajoki KJ, Jaatinen S, Hartewig
A, Tiihonen AM, Annala M, Salonen I, Valkonen M, Simola V,
Vuorinen EM, Kivinen A, Rauhala MJ, Nurminen R, Maass KK, Lahtela
SL, Jukkola A, Yli-Harja O, Helén P, Pajtler KW, Ruusuvuori
P, Haapasalo J, Zhang W, Haapasalo H, Nykter M.
Genomic
characterization of IDH-mutant astrocytoma progression to grade 4
in the treatment setting.
Acta
Neuropathol Commun. 2023 Nov 6;11(1):176∟.
doi: 10.1186/s40478-023-01669-9∟.
PMID: 37932833∟.
Observational study. ˍ
Xiao X, Yang N, Gu G, Wang X, Jiang
Z, Li T, Zhang X, Ma L, Zhang P, Liao H, Zhang L.
Diffusion
MRI is valuable in brainstem glioma genotyping with quantitative
measurements of white matter tracts.
Eur
Radiol. 2023 Nov 6∟.
doi: 10.1007/s00330-023-10377-w∟.
PMID: 37926739∟.
Observational study˰ ˍ
Zamanian M, Abedi I, Danazadeh F,
Amouheidari A, Shahreza BO.
Post-chemo-radiotherapy
response and pseudo-progression evaluation on glioma cell types by
multi-parametric magnetic resonance imaging: a prospective
study.
BMC Med
Imaging. 2023 Nov 6;23(1):176∟.
doi: 10.1186/s12880-023-01135-x∟.
PMID: 37932656∟.
Interventional study. ˍ
Friedman HS, Prados MD, Wen PY,
Mikkelsen T, Schiff D, Abrey LE, Yung WKA, Paleologos N, Nicholas
MK, Jensen R, Vredenburgh J, Huang J, Zheng M, Cloughesy
T.
Bevacizumab
Alone and in Combination With Irinotecan in Recurrent
Glioblastoma.
J
Clin Oncol. 2023 Nov 7;41(32):4945-4952∟.
doi: 10.1200/JCO.22.02772∟.
PMID: 37935104∟.
Interventional study˰ ˍ
Corrected
and republished from:
Friedman HS, et al., Bevacizumab
alone and in combination with irinotecan in recurrent
glioblastoma.
J
Clin Oncol. 2009 Aug 31;27(28):4733-40∟.
doi: 10.1200/JCO.2008.19.8721∟.
PMID: 19720927∟.
Interventional study. ˍ
Arrieta VA, Duerinck J, Burdett KB,
Habashy KJ, Geens W, Gould A, Schwarze JK, Dmello C, Kim KS,
Saganty R, Chen L, Moscona A, McCord M, Lee-Chang C, Horbinski CM,
Zhang H, Stupp R, Neyns B, Sonabend AM.
ERK1/2
Phosphorylation Predicts Survival in Recurrent Glioblastoma
Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A
REMARK-Guided Analysis.
Clin
Cancer Res. 2023 Nov 8∟.
doi: 10.1158/1078-0432.CCR-23-1889∟.
PMID: 37939133∟.
Interventional study˰ ˍ
Gasanz Garicochea M,
Martínez-Romera I, Osuna-Marco MP, López-Ibor Aliño
B.
Clinical
experience with immunotherapy in patients with diffuse intrinsic
pontine glioma.
Eur
J Hosp Pharm. 2023 Nov 8:ejhpharm-2022-003511∟.
doi: 10.1136/ejhpharm-2022-003511∟.
PMID: 37940368∟.
Observational study˰ ˍ
Wang Y, Duggar WN, Caballero DM,
Thomas TV, Adari N, Mundra EK, Wang H.
A
brain MRI dataset and baseline evaluations for tumor recurrence
prediction after Gamma Knife radiotherapy.
Sci
Data. 2023 Nov 8;10(1):785∟.
doi: 10.1038/s41597-023-02683-1∟.
PMID: 37938247∟.
Observational study. ˍ
*
Williamson C, Williamson S, Jiang
R, Sudmeier L, Esiashvili N, Eaton BR.
The
impact of radiation therapy variables on pediatric high-grade
glioma outcomes: A National Cancer Database analysis.
Pediatr
Blood Cancer. 2023 Nov 8:e30751∟.
doi: 10.1002/pbc.30751∟.
PMID: 37937991∟.
Observational study˰ ˍ
Yagasaki A, Miyase T, Sakai S,
Mochizuki K, Sakaguchi H, Yagasaki T, Ohe N, Yasue S, Endo S,
Ozeki M.
Two
Pediatric Patients with Acute Acquired Comitant Esotropia as the
First Symptom of Brainstem Tumor: A Case Report.
Case
Rep Ophthalmol. 2023 Nov 8;14(1):613-619∟.
doi: 10.1159/000534709∟.
PMID: 37946847∟.
Case report. ˍ
Akinduro OO, Ghaith AK, Loizos M,
Lopez AO, Goyal A, de Macêdo Filho L, Ghanem M, Jarrah R,
Moniz Garcia DP, Abode-Iyamah K, Kalani MA, Chen SG, Krauss WE,
Clarke MJ, Bydon M, Quiñones-Hinojosa A.
What
Factors Predict the Development of Neurologic Deficits Following
Resection of Intramedullary Spinal Cord Tumors: A Multi-Center
Study.
World
Neurosurg. 2023 Nov 10:S1878-8750(23)01573-5∟.
doi: 10.1016/j.wneu.2023.11.010∟.
PMID: 37952880∟.
Observational study˰ ˍ
Khan AB, Dang HQ, Gopakumar S,
Lazaro T, Gadgil N, Baxter P, Malbari F, Aldave G.
Clinical
outcomes of stereotactic biopsy on children with pontine diffuse
midline glioma.
J
Neurooncol. 2023 Nov 9∟.
doi: 10.1007/s11060-023-04475-4∟.
PMID: 37945818∟.
Observational study˰ ˍ
Lau KS, Ruisi I, Back
M.
Association
of MRI Volume Parameters in Predicting Patient Outcome at Time of
Initial Diagnosis of Glioblastoma.
Brain
Sci. 2023 Nov 10;13(11):1579∟.
doi: 10.3390/brainsci13111579∟.
PMID: 38002539∟.
Observational study. ˍ
Brighi C, Puttick S, Woods A, Keall
P, Tooney PA, Waddington DEJ, Sproule V, Rose S, Fay M.
Comparison
between [68Ga]Ga-PSMA-617
and [18F]FET
PET as Imaging Biomarkers in Adult Recurrent Glioblastoma.
Int
J Mol Sci. 2023 Nov 11;24(22):16208∟.
doi: 10.3390/ijms242216208∟.
PMID: 38003399∟.
Observational study. ˍ
Kilic Durankus N, Samanci Y,
Düzkalir AH, Peker S.
Unveiling
the Efficacy of Gamma Knife Radiosurgery for Tectal Plate
Gliomas.
Neurosurgery.
2023 Nov 13∟.
doi: 10.1227/neu.0000000000002754∟.
PMID: 37955438∟.
Observational study, Review˰ ˍ
Shah A, Marianayagam NJ, Zamarud A,
Park DJ, Persad AR, Soltys SG, Chang SD, Veeravagu A.
Spinal
metastases of pineal region glioblastoma with primitive
neuroectodermal features highlighting the importance of molecular
diagnoses: illustrative case.
J
Neurosurg Case Lessons. 2023 Nov 13;6(20):CASE23536∟.
doi: 10.3171/CASE23536∟.
PMID: 37956418∟.
Case report. ˍ
*
Wan Y, Li G, Deng J, Zhu H, Ma X.
A
gene signature predicting prognosis of patients with lower-grade
gliomas receiving temozolomide therapy.
Discov
Oncol. 2023 Nov 13;14(1):202∟.
doi: 10.1007/s12672-023-00818-9∟.
PMID: 37955724∟.
Observational study, Nomogram. ˍ
*
Guo X, Qiu W, Wang C, Qi Y, Li B,
Wang S, Zhao R, Cheng B, Han X, Du H, Gao Z, Pan Z, Zhao S, Li G,
Xue H.
Neuronal
activity promotes glioma progression by inducing
proneural-to-mesenchymal transition in glioma stem cells.
Cancer
Res. 2023 Nov 14∟.
doi: 10.1158/0008-5472.CAN-23-0609∟.
PMID: 37963207∟.
Laboratory investigation˰ ˍ
Salles D, Santino SF, Diana P,
Malinverni ACM, Stávale JN.
Pilocytic
astrocytoma in adults: Histopathological, immunohistochemical and
molecular study with clinical association.
Pathol
Res Pract. 2023 Nov 14;252:154942∟.
doi: 10.1016/j.prp.2023.154942∟.
PMID: 37984046∟.
Observational study˰ ˍ
Kim EH.
Tumor
treating fields induced senescence on glioblastoma.
Am
J Cancer Res. 2023 Nov 15;13(11):5626-5640∟.
PMID: 38058802∟.
Laboratory investigation. ˍ